
About REFSYN
REFSYN is a Healthcare company based in Puducherry (India). Custom synthesis, contract research, and supply of API impurities and metabolites in India. It operates in the Healthcare and Chemicals & Materials sectors. Its Indian entity Refsyn Biosciences Private Limited reported revenue of βΉ23.7 Lakh. REFSYN offers products and services including API Impurities and Metabolites. Its focus areas include Pharmaceuticals, API Manufacturing, Impurities and Metabolites and Agriculture.
Company details
REFSYN BIOSCIENCES was established in 2012 in Puducherry, India, as an ISO 9001:2015 certified custom synthesis and contract research organization. It is recognized for manufacturing and exporting API impurities, drug metabolites, and certified reference standards to support pharmaceutical, biomedical, biotechnology, and agrochemical sectors. Products are intended solely for research and analytical purposes, with services including technology transfer and analytical support. The company operates under government registration and focuses on providing standards like USP, EP, and JP for industry needs.
- Headquarters Puducherry, India
- SectorsHealthcareChemicals & Materials
- Emailβ’β’β’β’β’β’β’β’
- Phoneβ’β’β’β’ β’β’β’β’
- Website refsyn.com
- Social X YouTube
- Legal Name Refsyn Biosciences Pvt Ltd
- Date of Incorporation 10 Jan, 2012
- Jurisdiction Puducherry, India
- Annual Revenue₹23.7 Lakh
FY 2025 · +30% YoY
- Net Loss-₹11.9 Lakh
FY 2025 · -50% margin
- EBITDA-₹10.9 Lakh
FY 2025 · -46% margin
Associated legal entities of REFSYN
REFSYN operates through Refsyn Biosciences Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Refsyn Biosciences Private Limited CIN U74900PY2012PTC002664 | Active | 10 Jan 2012 | Puducherry, Puducherry | ₹0.2 Cr | 2 | View details |
Products & Services of REFSYN
REFSYN offers a comprehensive portfolio of products and services, including API Impurities and Metabolites.
API impurities are manufactured and supplied for research and analytical applications in the pharmaceutical sector
Drug metabolites are provided as standards for analytical use in pharmaceutical and biomedical research
Apps and channels of REFSYN
its YouTube channel REFSYN BIOSCIENCES PRIVATE LIMITED has 33 subscribers and 10 videos.
Videos from REFSYN
The most watched videos on REFSYN's YouTube channel, REFSYN BIOSCIENCES PRIVATE LIMITED (33 subscribers). Click a video to play it here.
More on REFSYN BIOSCIENCES PRIVATE LIMITED.
Board of directors of Refsyn Biosciences Private Limited (REFSYN)
Refsyn Biosciences Private Limited is the primary company behind REFSYN. The board of Refsyn Biosciences Private Limited currently have 2 directors; the longest-serving is Geetha Subramanian, appointed in 2012. 2 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Geetha Subramanian DIN 05164533 | Director | 10 Jan 2012 | 14 yrs 10 mo | Refsyn Biosciences Private Limited |
| Arun Mohambaram DIN 08752892 | Director | 03 Jun 2020 | 6 yrs 5 mo | Refsyn Biosciences Private Limited |
Financials of REFSYN
Figures of Refsyn Biosciences Private Limited, the primary company behind REFSYN, for FY 2025. Revenue was ₹23.7 Lakh (+30% year on year). Net loss was -₹11.9 Lakh (-50% margin). EBITDA was -₹10.9 Lakh (-46% margin). Revenue has grown at a compounded annual rate of -23% over three years and -7% over five years.
- ₹23.7 LakhRevenue · FY 2025 · +30% YoY
- -₹11.9 LakhNet loss · -50% margin
- -₹10.9 LakhEBITDA · -46% margin
- ₹1 LakhPaid-up capital
- -23%Revenue CAGR, 3 years
- -7%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Refsyn Biosciences Private Limited are on its company page.
Detailed financial statements for REFSYN
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Web traffic of REFSYN
The website of REFSYN (refsyn.com) receives about 1.3K visits a month.
- Monthly visits1.3K
▼ 19.9% vs previous month
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about REFSYN
REFSYN is headquartered in Puducherry, India. It is registered at Puducherry, Puducherry, India.
The primary company behind REFSYN, Refsyn Biosciences Private Limited, reported revenue of βΉ23.7 Lakh for FY 2025, up 30% year on year.
REFSYN BIOSCIENCES was established in 2012 in Puducherry, India, as an ISO 9001:2015 certified custom synthesis and contract research organization. It is recognized for manufacturing and exporting API impurities, drug metabolites, and certified reference standards to support pharmaceutical, biomedical, biotechnology, and agrochemical sectors. Products are intended solely for research and analytical purposes, with services including technology transfer and analytical support. The company operates under government registration and focuses on providing standards like USP, EP, and JP for industry needs.
REFSYN offers API Impurities and Metabolites.
REFSYN operates through Refsyn Biosciences Private Limited.
The legal entities of REFSYN currently have 2 directors, including Arun Mohambaram, Geetha Subramanian.